West Pharmaceutical Services Inc banner

West Pharmaceutical Services Inc
SWB:WPS

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
SWB:WPS
Watchlist
Price: 296.3 EUR 0.71% Market Closed
Market Cap: €21.9B

Wall St Price Targets

WPS Price Targets Summary
West Pharmaceutical Services Inc

Wall Street analysts forecast WPS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WPS is 360.25 EUR with a low forecast of 293.2 EUR and a high forecast of 415.16 EUR.

Lowest Forecast
Price Target
293.2 EUR
1% Downside
Average Forecast
Price Target
360.25 EUR
22% Upside
Highest Forecast
Price Target
415.16 EUR
40% Upside
West Pharmaceutical Services Inc Competitors:
Price Targets

Revenue
Forecast

7% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.

Gross Profit
Forecast

8% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 11%.

Operating Income
Forecast

12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 5 years is 13%.

Pre-Tax Income
Forecast

14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 19%.

Net Income
Forecast

15% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
15% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 5 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is WPS's stock price target?
Price Target
360.25 EUR

According to Wall Street analysts, the average 1-year price target for WPS is 360.25 EUR with a low forecast of 293.2 EUR and a high forecast of 415.16 EUR.

What is the Revenue forecast for West Pharmaceutical Services Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.

What is the Gross Profit forecast for West Pharmaceutical Services Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 11%.

What is the Operating Income forecast for West Pharmaceutical Services Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 5 years is 13%.

What is the Pre-Tax Income forecast for West Pharmaceutical Services Inc?
Projected CAGR
19%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 19%.

What is the Net Income forecast for West Pharmaceutical Services Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 5 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett